Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1974;43:658-664
© 1974 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by RAGNI, M. V.
Right arrow Articles by TOBON, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by RAGNI, M. V.
Right arrow Articles by TOBON, H.

Primary Malignant Melanoma of the Vagina and Vulva

MARGARET V. RAGNI, BS and HECTOR TOBON, MD

From the Department of Pathology, Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Address reprint requests to Hector Tobon, MD Department of Pathology Magee-Womens Hospital Forbes A venue and Halket Street Pittsburgh, PA 15213

Eleven cases of primary malignant melanoma of the female genital tract, included in the Magee-Womens Hospital Tumor Registry from 1947 to 1972, were reviewed. Clinical and pathologic findings were compiled, and lesions were retrospectively staged and compared with studies in the literature. Five cases involved the vagina; 6 involved the vulva. The mean age was 62 years, and the most frequently reported symptoms were bleeding (72.7%) and a lump or mass (54.59%). Three patients showed metastases to regional lymph nodes at the time of original surgery, and 6 later developed metastases to the bladder, pelvis, lung, meninges, and/or nerve roots. The best survival rate was associated with radical surgery along with lymph node dissection. The prognosis for tumors in the vagina was worse than for those in the vulva, with a mean survival of 19.4 months and 36.6 months, respectively.




This article has been cited by other articles:


Home page
 Arch DermatolHome page
J. A. Carlson, X. C. Mu, A. Slominski, K. Weismann, A. N. Crowson, J. Malfetano, V. G. Prieto, and M. C. Mihm Jr
Melanocytic Proliferations Associated With Lichen Sclerosus
Arch Dermatol, January 1, 2002; 138(1): 77 - 87.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1974 by the American College of Obstetricians and Gynecologists.